ofatumumab
Modify Date: 2024-01-02 19:39:59
ofatumumab structure
|
Common Name | ofatumumab | ||
|---|---|---|---|---|
| CAS Number | 679818-59-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ofatumumabOfatumumab (Arzerra) is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes[1]. |
| Name | ofatumumab |
|---|
| Description | Ofatumumab (Arzerra) is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Sanford M, McCormack PL. Ofatumumab. Drugs. 2010;70(8):1013-1019. |
| No Any Chemical & Physical Properties |